p53 functions as a central node for organizing whether the cell responds to various types and levels of stress via apoptosis, cell cycle arrest, senescence, DNA repair, cell metabolism, autophagy and aging. While the exact molecular events for p53-mediated choice of cell fate are still insufficiently explained, p53 controlled transactivation of target genes comprises an essential event in each stress response pathway. As a transcription factor, p53 demands an exquisitely complicated network of control and fine-tuning mechanisms to ensure correct, differentiated responses to the various stress signals encountered by cells. p53 was the first non-histone protein known to be regulated by acetylation (Gu and Roeder, 1997). The acetylation levels of p53 are significantly enhanced in response to stress, and correlate well with p53 activation and stabilization in all cell types in respond to almost every type of stress. Following our early findings of C-terminus p53 acetylation, we and others recently showed that p53 is also acetylated by Tip60/hMOF at residue K120 within the DNA binding domain (Tang et al., 2006;Sykes et al., 2006). K120 acetylation is crucial for p53-mediated apoptosis but has no obvious effect on p21 expression, an essential target of p53-mediated growth arrest. More recently, we have identified K164 as a new site for in vivo acetylation of p53 by GBP/p300 and evaluated its function in p21 activation. Although acetylation defects at each individual site (K164, K120, and C-terminus) can be compensated by the modification of other sites, loss of acetylation at all these major sites completely abolishes p53's ability to activate its mediated cell growth arrest and apoptosis. These studies demonstrate an indispensible role of acetylation in p53 regulation (Tang et al., 2008). On the other hand, p53 is tightly regulated by Mdm2 and its related protein Mdmx. Nonetheless, the molecular mechanisms by which p53 activity is controlled by Mdm2 and Mdmx are complex (Brooks and Gu, 2006). Mdm2 and MdmX are structurally related proteins and physiological levels of both proteins are required in a non redundant manner to balance p53 activity during embryonic development. Notably, our recent studies show that acetylation of p53 abrogates Mdm2- and Mdmx-mediated repression by blocking the recruitment of Mdm2 or Mdmx to p53 responsive promoters (Tang et al., 2008). Our study identifies anti-repression as a major mechanism for acetylation-mediated p53 activation in stress responses. In summary, for the past 10 years, our lab has made significant contributions to understand this dynamic pathway of p53 regulation by protein modifications. The central hypothesis to be tested here is that protein modification of p53 such as acetylation plays a major part in the scope of controlling p53 function by directly affecting the interactions of p53 with Mdm2/Mdmx or other cellular regulators in vivo, which enables p53 to activate transcription in a promoter-specific manner. It includes the following two specific aims.
In Aim 1 we will elucidate the precise roles of p53 acetylation in releasing the repression of p53 from Mdm2 and Mdmx.
In Aim 2, we will identify additional cellular factors involved in anti-repression mechanisms and investigate the roles of these factors in modulating p53 activities in stress responses.

Public Health Relevance

The p53 tumor suppressor is mutated in every type of human cancers. p53-mediated transcriptional activation is essential for its ability in suppressing tumor formation. This study will elucidate the molecular mechanisms for p53 activation in tumor suppression and yield crucial insights regarding how to target this pathway in cancer therapy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA080058-13
Application #
8376275
Study Section
Special Emphasis Panel (ZCA1-GRB-S)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
13
Fiscal Year
2012
Total Cost
$357,028
Indirect Cost
$77,804
Name
Icahn School of Medicine at Mount Sinai
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Tavana, Omid; Li, Dawei; Dai, Chao et al. (2016) HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma. Nat Med 22:1180-1186
Ou, Yang; Wang, Shang-Jui; Li, Dawei et al. (2016) Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci U S A 113:E6806-E6812
Li, Tongyuan; Liu, Xiangyu; Jiang, Le et al. (2016) Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging. Oncotarget 7:11838-49
Mungamuri, Sathish Kumar; Qiao, Rui F; Yao, Shen et al. (2016) USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation. Cell Rep 14:2528-37
Hwang, So-Young; Deng, Xianming; Byun, Sanguine et al. (2016) Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling. Cell Rep 16:28-36
Shi, D; Dai, C; Qin, J et al. (2016) Negative regulation of the p300-p53 interplay by DDX24. Oncogene 35:528-36
Ou, Yang; Wang, Shang-Jui; Jiang, Le et al. (2015) p53 Protein-mediated regulation of phosphoglycerate dehydrogenase (PHGDH) is crucial for the apoptotic response upon serine starvation. J Biol Chem 290:457-66
Hiraki, Masatsugu; Hwang, So-Young; Cao, Shugeng et al. (2015) Small-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory Axis. Chem Biol 22:1206-16
Resnick-Silverman, Lois; Manfredi, James J (2015) Two Faces of SIVA. Cancer Discov 5:581-3
Jiang, Le; Kon, Ning; Li, Tongyuan et al. (2015) Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520:57-62

Showing the most recent 10 out of 76 publications